All-In with Chamath, Jason, Sacks & Friedberg Howard Lutnick: How America Can Hit 6% GDP Growth in 2026
1427 snips
Jan 9, 2026 
Howard Lutnick, the United States Secretary of Commerce, shares insights from his impactful role and past as a business leader. He humorously recounts an Air Force One story and discusses the scope of the Commerce Department. Lutnick explains the intricacies of tariffs, revealing how they are utilized to reshape trade dynamics. The conversation also dives into strategies for achieving 5-6% GDP growth by 2026, negotiation challenges with India, and efforts to lower pharmaceutical costs while tackling fraud. It's a compelling blend of policy and humor!
AI Snips
Chapters
Transcript
Episode notes
MFN Pricing As Fairness For U.S. Buyers
- The U.S. pays disproportionately high drug prices and can demand Most-Favored-Nation pricing from big pharma.
- Lutnick framed MFN as fairness: largest customer should not pay more than other wealthy nations.
Leverage Tariffs To Reprice Drugs
- Combine regulatory pressure with incentives: demand MFN pricing and offer tariff waivers for reshoring.
- Use the threat of steep tariffs as leverage to secure drug price cuts and manufacturing relocation to the U.S.
Immediate Savings From Drug Deals
- Negotiations produced dramatic drug-price outcomes like Ozempic pricing moves for Medicaid and Medicare.
- Some companies committed major savings or even donation of drugs to government programs.